NKG2D is a special receptor expressed in NK cells and T cells, previous research demonstrated that the high‐affinity NKG2D ligand released by tumor cells can stimulate NK cells and enhance their antitumor functions [162]. The gene discussed is KLRK1; the disease is neoplasm.